Explore

Reuters Reuters
CVS raises annual profit forecast on improved drug revenue

CVS raises annual profit forecast on improved drug revenue

By Amina Niasse NEW YORK, Aug 5 (Reuters) - CVS Health on Wednesday raised its annual profit forecast to reflect a better-than-expected second quarter marked by a more profitable mix of drugs in its pharmacy business and bonus payments for its highly rated government health plans.
Reuters Reuters
CVS raises annual profit forecast on improved drug revenues

CVS raises annual profit forecast on improved drug revenues

By Amina Niasse NEW YORK, Aug 5 (Reuters) - CVS Health on Wednesday raised its annual profit forecast to reflect a better-than-expected second quarter marked by a more profitable mix of drugs in its pharmacy business and bonus payments for its highly rated government health plans.
Reuters Reuters
Lilly's Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk

Lilly's Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk

By Mrinalika Roy and Mariam Sunny Aug 5 (Reuters) - Sales of Eli Lilly's Zepbound and Mounjaro injectable weight-loss and diabetes drugs soared during the second quarter, easily beating Wall Street estimates and widening the gap with Danish rival Novo Nordisk.
Reuters Reuters
Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Aug 5 (Reuters) - Eli Lilly and Co posted better-than-expected quarterly results and raised its full-year revenue forecast on Wednesday, banking on sustained demand for its blockbuster GLP-1 weight-loss and diabetes drugs, sending its shares up 5% in premarket trading.
Reuters Reuters
Novo outlook hike falls flat as high Wegovy pill hopes unmet

Novo outlook hike falls flat as high Wegovy pill hopes unmet

By Stine Jacobsen and Maggie Fick COPENHAGEN, Aug 4 (Reuters) - Novo Nordisk beat second-quarter profit forecasts and raised its full-year outlook on Wednesday, but shares in the drugmaker fell 6% as investors focused on underwhelming sales of its Wegovy weight-loss pill.
Trendline Trendline
Novo Nordisk Shares Decline After Disappointing Guidance

Novo Nordisk Shares Decline After Disappointing Guidance

Novo Nordisk Shares Decline After Disappointing Guidance
Reuters Reuters
Analysis-Obesity battle heats up again as Novo claws way back into race with Lilly

Analysis-Obesity battle heats up again as Novo claws way back into race with Lilly

By Maggie Fick and Bhanvi Satija LONDON, Aug 3 - Novo Nordisk investors have found little cause for optimism during a bruising two-year period of profit warnings, leadership upheaval and a sliding share price as rival Eli Lilly streaked ahead. Now they may have reason for hope.
Trendline Trendline
SB1 Markets Recommends Buying Novo Nordisk Stock Ahead of Earnings Report

SB1 Markets Recommends Buying Novo Nordisk Stock Ahead of Earnings Report

SB1 Markets Recommends Buying Novo Nordisk Stock Ahead of Earnings Report
Trendline Trendline
CVS Health Exceeds Q2 Earnings Expectations, Raises 2026 Guidance Amid Insurance Unit Recovery

CVS Health Exceeds Q2 Earnings Expectations, Raises 2026 Guidance Amid Insurance Unit Recovery

CVS Health Exceeds Q2 Earnings Expectations, Raises 2026 Guidance Amid Insurance Unit Recovery
Reuters Reuters
Carlyle tops profit expectations on pick-up in fees, deals

Carlyle tops profit expectations on pick-up in fees, deals

Aug 5 (Reuters) - Global investment firm Carlyle topped Wall Street estimates for second-quarter profit on Wednesday, as fee-related earnings climbed and the group booked proceeds from deals in Japan and the U.S.
Reuters Reuters
Novo outlook hike falls flat as Wegovy pill sales fail to impress

Novo outlook hike falls flat as Wegovy pill sales fail to impress

By Stine Jacobsen, Maggie Fick and Bhanvi Satija COPENHAGEN, Aug 4 (Reuters) - Novo Nordisk raised its full-year profit and sales outlook on Tuesday but disappointed investors who focused instead on a narrow sales miss for its new Wegovy pill and a trial setback for its next-generation obesity drug
Reuters Reuters
European shares hover near record highs as earnings offset Mideast uncertainty

European shares hover near record highs as earnings offset Mideast uncertainty

By Tharuniyaa Lakshmi and Ragini Mathur August 5 (Reuters) - European shares were muted on Wednesday as investors assessed a fresh batch of corporate earnings while keeping an eye on fast-moving developments in the Middle East.